Janus Henderson Group’s AnaptysBio ANAB Stock Holding History

Janus Henderson Group’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$414K	Hold	7,464	–	–	﹤0.01%	2096
2025 Q4	$362K	Hold	7,464	–	–	﹤0.01%	2139
2025 Q3	$229K	Buy	+7,464	New	+$171K	﹤0.01%	2298
2024 Q4	–	Sell	-7,464	Closed	-$250K	–	2526
2024 Q3	$250K	Buy	+7,464	New	+$255K	﹤0.01%	2349
2019 Q4	–	Sell	-2,503,622	Closed	-$87.6M	–	1417
2019 Q3	$87.6M	Sell	2,503,622 -677,817	-21%	-$32.2M	0.05%	411
2019 Q2	$179M	Sell	3,181,439 -98,192	-3%	-$7.07M	0.1%	238
2019 Q1	$240M	Sell	3,279,631 -109,353	-3%	-$7.55M	0.13%	187
2018 Q4	$216M	Buy	3,388,984 +245,829	+8%	+$18.3M	0.14%	182
2018 Q3	$314M	Buy	3,143,155 +312,833	+11%	+$26M	0.17%	158
2018 Q2	$201M	Buy	2,830,322 +882,440	+45%	+$74M	0.11%	221
2018 Q1	$203M	Buy	1,947,882 +502,086	+35%	+$56.6M	0.12%	216
2017 Q4	$146M	Buy	+1,445,796	New	+$106M	0.09%	263

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Janus Henderson Group's ANAB Position: Q1 2026 in Review

Janus Henderson Group held its AnaptysBio (ANAB) position steady in Q1 2026 at 7,464 shares worth $414K. The position accounts for ﹤0.01% of the portfolio, ranked #2096.

Janus Henderson Group first reported a position in ANAB in Q4 2017 and has held it in 12 quarters since. The position peaked at $314M in Q3 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

Janus Henderson Group held 7,464 shares of AnaptysBio worth $414K as of Q1 2026.
Janus Henderson Group left its AnaptysBio share count unchanged in Q1 2026.
AnaptysBio made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2096 holding.
Janus Henderson Group first reported a position in AnaptysBio in Q4 2017 and has held it in 12 quarters since.
Janus Henderson Group's AnaptysBio position peaked at $314M in Q3 2018.
207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.